Table 2.
Carcinologic characteristics of the BC cohort (n = 25).
| Type of Cancer | |
|---|---|
| Invasive Carcinoma of No Special Type (Ductal) | 19 (76.0%) |
| Invasive Lobular Carcinoma | 6 (24.0%) |
| Histoprognostic Grade | |
| Grade I | 5 (20.0%) |
| Grade II | 16 (64.0%) |
| Grade III | 4 (16.0%) |
| Clinical Stage | |
| I | 21 (84.0%) |
| IIa | 3 (12.0%) |
| IIIb | 1 (4.0%) |
| Tumoral Overexpression Receptors | |
| ER/Pg+ | 25 (100%) |
| HER2+ | 0 |
| Tumour Localization | |
| unifocal | 23 (92.0%) |
| multifocal | 2 (8.0%) |
| size (mm) * | 12.5 (9.0–14.7) |
| Gene BRCA1/BRCA2 | 0 |
Expressed as n (percentage); * Median (25th–75th).